<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126467">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01456013</url>
  </required_header>
  <id_info>
    <org_study_id>RGS001D</org_study_id>
    <nct_id>NCT01456013</nct_id>
  </id_info>
  <brief_title>Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients</brief_title>
  <acronym>CIN-RG</acronym>
  <official_title>A Study to Evaluate RenalGuard® System Safety &amp; Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PLC Medical Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PLC Medical Systems, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Contrast-Induced Nephropathy (CIN) can occur when patients with pre-existing kidney problems
      undergo procedures that use iodinated contrast media, such as cardiac catheterizations.
      RenalGuard Therapy was developed to enable the patient to clear the contrast out of their
      kidney before it can do significant damage. This study aims to enroll patients with
      increased risk of developing CIN who are scheduled for a cardiovascular catheterization.
      Patients will be randomized to either RenalGuard therapy or standard therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Contrast Induced Nephropathy</measure>
    <time_frame>72 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac Events</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean peak increase in serum creatinine post contrast administration</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who develop CIN at 7 days post contrast administration</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who maintain a rise in serum creatinine at 7 days</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">326</enrollment>
  <condition>Contrast Induced Nephropathy</condition>
  <arm_group>
    <arm_group_label>Standard Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard of care for patients at risk of CIN</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RenalGuard Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induced Diuresis with Matched Replacement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RenalGuard Therapy</intervention_name>
    <description>Induced Diuresis with matched replacement</description>
    <arm_group_label>RenalGuard Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard Therapy</intervention_name>
    <description>Standard of care for patients at risk of CIN</description>
    <arm_group_label>Standard Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or non-pregnant female equal or greater than the age of 18 years old and is able
             to provide informed consent.

          -  Subject is scheduled to undergo an elective catheterization procedure

          -  Hemodynamically stable

          -  At increased risk of developing CIN

          -  Subject has agreed to all follow-up testing.

        Exclusion Criteria:

          -  Class 4 Congestive Heart Failure (CHF)or a documented left ventricular ejection
             fraction &lt; 30%

          -  Is anuric or has undergone renal replacement therapy within the past month, or has a
             known inability to have a Foley catheter placed.

          -  Subject has been hospitalized or treated medically for any change in renal function
             over the past week (i.e. dialysis, etc.), or a significant change in renal function
             is noted at time of screening.

          -  Has documented severe Aortic Stenosis.(Note: Subjects who have undergone successful
             replacement or repair of their aortic valve are not excluded.)

          -  Currently has a known clinically significant electrolyte imbalance or clinically
             significant arrhythmias which compromise subject's hemodynamic state.

          -  Patient has severe anemia (hemoglobin &lt; 8.0 g/dL) at screening

          -  Has received contrast within 10 days of procedure or has a planned additional cardiac
             or renal or other major surgical procedure within the 7 day follow-up period.

          -  Has ruled in for a Serious Heart Attack within 48 hours of the planned procedure

          -  Has documented respiratory insufficiency as evidenced by an oxygen saturation of &lt;
             90% on room air assessed on day of procedure.

          -  Planned addition, discontinuation or dose adjustment of nephrotoxic drugs

          -  Subject has a known hypersensitivity to furosemide and/or the contrast agent being
             used.

          -  Subject is currently, plans, or has been enrolled in another clinical study involving
             use of an investigational drug or device within the prior 30 days.

          -  Subject is pregnant or breastfeeding.

          -  Subject is unable to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Davidson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Solomon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Vermont</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roxana Mehran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew Halpert</last_name>
    <phone>508-520-2530</phone>
    <email>ahalpert@renalguard.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35924</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Johnson, BSN, RN</last_name>
    </contact>
    <contact_backup>
      <last_name>Sarah Carlson, BSN, RN</last_name>
    </contact_backup>
    <investigator>
      <last_name>Massoud Leesar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie DeClemente, RN</last_name>
    </contact>
    <contact_backup>
      <last_name>Emily Green</last_name>
    </contact_backup>
    <investigator>
      <last_name>Dominick Angiolillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Advocate Good Samaritan</name>
      <address>
        <city>Downers Grove</city>
        <state>Illinois</state>
        <zip>60515</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Rogers, MSN, RN</last_name>
      <phone>630-785-2079</phone>
    </contact>
    <investigator>
      <last_name>Mahesh Raju, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advocate Health</name>
      <address>
        <city>Naperville</city>
        <state>Illinois</state>
        <zip>65040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Yanz, RN, BSN</last_name>
    </contact>
    <investigator>
      <last_name>Mark Goodwin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth's Hospital</name>
      <address>
        <city>Brighton</city>
        <state>Massachusetts</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsay Pothier</last_name>
    </contact>
    <investigator>
      <last_name>Joseph P Carrozza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cape Cod Healthcare</name>
      <address>
        <city>Hyannis</city>
        <state>Massachusetts</state>
        <zip>02601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelcie Brown, RN, BSN</last_name>
      <phone>508-778-5900</phone>
    </contact>
    <investigator>
      <last_name>Richard Zelman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noelle Bodkin, BSN</last_name>
    </contact>
    <investigator>
      <last_name>Jeffrey Rade, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph Medical Center</name>
      <address>
        <city>St. Charles</city>
        <state>Missouri</state>
        <zip>63301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>NYU Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Candido Batres, RN</last_name>
      <phone>212-342-3486</phone>
    </contact>
    <contact_backup>
      <last_name>Kate Dalton, MS</last_name>
    </contact_backup>
    <investigator>
      <last_name>Ziad Ali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>NY</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Safwan Kezbor</last_name>
    </contact>
    <investigator>
      <last_name>George Dangas, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Rex Hospital</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kerry Finch, BSN</last_name>
    </contact>
    <investigator>
      <last_name>Deepak Pasi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. John Research Institute</name>
      <address>
        <city>Bartlesville</city>
        <state>Oklahoma</state>
        <zip>74006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenny Doggett, RN</last_name>
    </contact>
    <contact_backup>
      <last_name>Stephanie McCartney, RN</last_name>
    </contact_backup>
    <investigator>
      <last_name>Andrew Kurklinsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Bollino, RN, BSN</last_name>
    </contact>
    <contact_backup>
      <last_name>Mary C Coast</last_name>
    </contact_backup>
    <investigator>
      <last_name>Catalin Toma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guthrie Medical Center</name>
      <address>
        <city>Sayre</city>
        <state>Pennsylvania</state>
        <zip>18840</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Franchetti, RN</last_name>
    </contact>
    <investigator>
      <last_name>J. Dawn Abbott, MD, FACC, FSCAI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Gordon, RN</last_name>
    </contact>
    <investigator>
      <last_name>Paul Gordon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Heart</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paige Musick, RN, BSN</last_name>
    </contact>
    <contact_backup>
      <last_name>Nancy Tilton</last_name>
    </contact_backup>
    <investigator>
      <last_name>Mark Picone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 2, 2017</lastchanged_date>
  <firstreceived_date>October 18, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
